Global Hemophilia Management Market Outlook 2015 to 2020 Oct.2016 | Page 2

Global Hemophilia Management Market According to the report “Hemophilia Management Market”, published by Market Data Forecast, the global market is projected to reach USD 5616 million by 2020, at a CAGR of 1.62% from 2015 to 2020. For full report refer to http://www.marketdataforecast.com/market-reports/globalhemophilia-management-market-310/ Hemophilia is a genetic disorder which impairs body`s ability to control blood clotting. Hemophilia usually occurs in males it is estimated that about 1 in 5000 males that are born each year contain hemophilia. The worldwide incidence of hemophilia is estimated at more than 400,000 people. It is estimated that about 75% of the hemophilia patients do not receive adequate treatment Free sample for the report is available at http://www.marketdataforecast.com/marketreports/global-hemophilia-management-market-310/request-sample Growing prevalence of the disease and increasing usage of recombinant product is expected to drive the market growth. Technological advancements and advancements in the novel coagulating factors and are also fuelling the growth of global Hemophilia Management market. Rising investments in Research and developments for hemophilia products is also driving the market growth. However lack of available medication, awareness of this disease and high cost of treatment are the major restraining factors in the market. Advancements in gene therapy and increasing number of drug approvals for treatment of hemophilia provide immense growth opportunities in the market. Global Hemophilia Management Market 1.Condition Type   Hemophilia A Hemophilia B 2. Drug Type     Octocogalfa Nonacogalfa Desmopressin and other drugs 3.Geography      North America Europe Asia-Pacific Latin America Africa & Middle-East [phone] | www.marketdataforecast.com | [email protected]